GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹570 Cr | ₹708 Cr | ₹625 Cr | ₹428 Cr | ₹579 Cr |
What is the latest Trade Payables ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹570 Cr |
| Mar2025 | ₹708 Cr |
| Mar2024 | ₹625 Cr |
| Mar2023 | ₹428 Cr |
| Mar2022 | ₹579 Cr |
How is Trade Payables of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹570 Cr | -19.49 | |
| Mar2025 | ₹708 Cr | 13.25 | |
| Mar2024 | ₹625 Cr | 46.20 | |
| Mar2023 | ₹428 Cr | -26.16 | |
| Mar2022 | ₹579 Cr | - | |
Compare Trade Payables of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,921.8 Cr | 7% | 6.7% | -4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 7% |
6.7% |
-4.6% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses